News Agency News Aggregator Journalist/Editor Broking House Others
#Multi/Broker tips (11th November Result 2019) 1. SUNTV FO (Profit Rs 8000/Lot) 2. TITAN FO (Loss Rs -5250/Lot) 3. UPL EQ (Profit Rs 10/Share) 4. AUROPHARMA EQ (Profit Rs 4/Share) 5. NIFTY Fut (Profit Rs 3375/Lot) 6. BANKNIFTY Fut (Loss Rs -2200/Lot)
#Equity/Cash Tips (11th November Result 2019) 1. UPL EQ (Profit Rs 10/Share) 2. AUROPHARMA EQ (Profit Rs 4/Share) #Share #Market #Tips, #Free #Trial Tips, #Equity Trial
HDFC Mutual Fund’s other top buys in October included SBI, Coal India, REC, Bajaj Corp, Bharti Infratel, Neyveli Lignite, Cipla, Ambuja Cement, Federal Bank, Texmaco Rail, Tata Steel, Lupin, Aurobindo Pharma, Firstsource Solutions and J Kumar Infraprojects, among others.
aaj bade dino baad #auropharma ka chart dekha ky se ky ho gaya dekhte dekhte
After update pullback high 507.5 Now @ 435 Also @ 5 year LOW #AuroPharma
Intraday watchlist HCLTECH-1141 HINDALCO-201.5 BPCL-504.5 AUROPHARMA-441 TATAMOTORS-170.2 Expecting a sell off in all...
Intraday watchlist HCLTECH HINDALCO BPCL AUROPHARMA
SBI Blue Chip Fund added Bandhan Bank to its investments and exited its position in Aurobindo Pharma in October, according to data analyzed by Bloomberg. The fund's disclosed holdings rose 1.1% in value to Rs225.4bn. #MOMarketUpdates
Today's (11th Nov 2019) #NiftyFuture Intraday Levels #BankniftyFuture Intraday Levels #StocksToWatch (BATAINDIA, AUROPHARMA, M&M and BPCL) updated visit #Nifty #Niftyfuture #NSE #Intraday #Awaazmarkets
#Aurobindo #Future 3 Consecutive close below 430+ weekly close...........................u will see 273---221 soon !!! #Bloodbath to continue !!
US FDA alerts recall of Ranitidine made by Aurobindo Pharma USA. #MOMarketUpdates
LM #MarketSnippets >#DLF net debt rises 31% to Rs 4461 crore. Co to become debt free in next one year >#Nestle Q3 net profit rises 33% to Rs 595 crore on higher domestic sales growth >#AurobindoPharma says talks with US FTC on Sandoz making progress #nifty #equity #investing
#Aurobindo Pharma clarified on the news of company’s buyout of Sandoz assets being delayed on FTC query is factually incorrect.
RT sanjeevsanyal: "I undermined an empire and it has not been rebuilt. I created a nation and it has not yet perished" - Chhatrapati Shivaji to Jaisingh (conversation as imagined by Sri Aurobindo):
Key Q2 earnings September quarter earnings season is entering its last leg. On Monday, traders will eye quarterly earnings from Adani Ports, Alkem Lab, Britannia, Hindalco, Motherson Sumi and NHPC; followed by Aurobindo Pharma and Godrej Industries on Tuesday.
#AuroPharma below 500/10 stock is not safe... On big timeframe stock chart is not looking good.... stock was trading in range of 500-895... Range total 395... Immediate support is 400...
#AUROPHARMA cmp @440 NEGATIVE zone Best entry @380 zone